Back
ESC Professional Premium Access

Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction

Session: Markers of inflammation and outcomes in patients with acute coronary syndromes
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor S. Cederstrom (Stockholm, SE)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Sofia Cederstrom

Karolinska Institute, Stockholm (Sweden)
0 follower

4 more presentations in this session

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab decreases myocardial inflammation in individuals with acute coronary syndrome (ACS)

Speaker: Doctor E. Ziogos (Baltimore, US)

Access
Abstract
Slides
Video
Thumbnail

Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients

Speaker: Doctor C. Materne (Paris, FR)

Access
Abstract
Slides
Video
Thumbnail

Analysis of immune infiltration and cuproptosis-related genes in acute myocardial infarction

Speaker: Doctor Y. Xiao (Changsha, CN)

Access
Abstract
Slides
Video
Thumbnail

Impact of nutritional status and systemic immune-inflammation index on mortality in patients with acute myocardial infarction

Speaker: Doctor H. Kwak (Daegu, KR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Markers of inflammation and outcomes in patients with acute coronary syndromes

Speakers: Doctor S. Cederstrom, Doctor E. Ziogos, Doctor C. Materne, Doctor Y. Xiao, Doctor H. Kwak
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb